HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2028-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of Hyperthermic Intravesical Chemotherapy (HIVEC) with Gemcitabine (GEM) after Transurethral Resection of Bladder Tumors (TURBT) in the treatment of medium or high-risk group Non-Muscle-Invasive Bladder Cancer (NMIBC).
Phase:
PHASE3
Details
Lead Sponsor:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University